Kintor Pharmaceutical Limited (9939.HK)
HKD 1.31
(9.17%)
HKD 1.31
(9.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 34.23 Thousand | - | - | 698.00 |
| Cost of Revenue | 42.22 Million | - | - | - | - | 689.00 |
| Gross Profit | -42.22 Million | - | 34.23 Thousand | - | - | 9.00 |
| Operating Expenses | 1.03 Billion | 951.97 Million | 885.88 Thousand | 515.26 Million | 232.81 Million | 109.24 Thousand |
| Selling, General and Administrative Expenses | 96.02 Million | 152.57 Million | 117.95 Thousand | 85.69 Million | 20.58 Million | 24.1 Thousand |
| Research and Development Expenses | 938.9 Million | 827.97 Million | 767.93 Thousand | 328.76 Million | 214.01 Million | 93.19 Thousand |
| Other Expenses | - | - | 419 Thousand | - | - | 9000.00 |
| Cost and Expenses | 1.07 Billion | 951.97 Million | 885.88 Thousand | 515.26 Million | 232.81 Million | 109.93 Thousand |
| Operating Income | -1.06 Billion | -969.12 Million | -834.69 Thousand | -399.74 Million | -218.21 Million | -109.63 Thousand |
| Interest Expense | - | - | 2.49 Million | - | - | 3.86 Million |
| Income Tax Expense | 8.04 Million | 1.08 Million | -229.82 Thousand | 73 Thousand | - | -159.86 Thousand |
| Earnings before Tax | -1.06 Billion | -953.28 Million | -842.09 Thousand | -508.22 Million | -232.57 Million | -108.48 Thousand |
| Net Income | -1.06 Billion | -954.36 Million | -842.09 Thousand | -508.3 Million | -232.57 Million | -108.48 Thousand |
| Earnings Per Share Basic | -2.47 | -2.53 | -2.36 | -1.64 | -0.97 | -0.50 |
| Earnings Per Share Diluted | -2.47 | -2.53 | -2.36 | -1.64 | -0.97 | -0.50 |
| Weighted Average Shares Outstanding | 429.06 Million | 376.56 Million | 356.39 Thousand | 309.35 Million | 239.36 Million | 218.37 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 429.06 Million | 376.56 Million | 356.39 Thousand | 309.35 Million | 239.36 Million | 218.37 Thousand |
| Gross Margin | - | - | 1.00 | - | - | 0.01 |
| EBIT Margin | - | - | -24.19 | - | - | -155.24 |
| Profit Margin | - | - | -24.60 | - | - | -155.42 |
| EBITDA | -1.05 Billion | -956.44 Million | -827.96 Million | -396.32 Million | -216.39 Million | -108.35 Million |
| Earnings Before Tax Margin | - | - | -24.38 | - | - | -157.07 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 42.22 Million | 42.22 Thousand | - | - | - | - |
| Gross Profit | -42.22 Million | -42.22 Thousand | - | - | - | - |
| Operating Expenses | 1.03 Billion | 814.75 Thousand | 215.26 Thousand | 951.97 Million | 431.73 Thousand | 520.24 Thousand |
| Selling, General and Administrative Expenses | - | 36.18 Thousand | 59.84 Thousand | - | 76.45 Thousand | 76.11 Thousand |
| Research and Development Expenses | - | 774.28 Thousand | 164.62 Thousand | - | 366.88 Thousand | 461.08 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.07 Billion | 856.98 Thousand | 215.26 Thousand | 951.97 Million | 431.73 Thousand | 520.24 Thousand |
| Operating Income | -1.06 Billion | -853.22 Thousand | -216.45 Thousand | -969.12 Million | -435.34 Thousand | -533.77 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 8.04 Million | 7534.00 | 507.00 | 1.08 Million | 1076.00 | 9.00 |
| Earnings before Tax | -1.06 Billion | -856.24 Thousand | -212.61 Thousand | -953.28 Million | -434.87 Thousand | -518.41 Thousand |
| Net Income | -1.06 Billion | -848.7 Thousand | -212.11 Thousand | -954.36 Million | -435.94 Thousand | -518.42 Thousand |
| Earnings Per Share Basic | - | -1.98 | -0.50 | - | -1.13 | -1.42 |
| Earnings Per Share Diluted | - | -1.98 | -0.50 | - | -1.13 | -1.42 |
| Weighted Average Shares Outstanding | 429.06 Million | 429.68 Thousand | 428.45 Thousand | 376.56 Million | 387.4 Thousand | 365.72 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 429.06 Million | 429.68 Thousand | 428.45 Thousand | 376.56 Million | 387.4 Thousand | 365.72 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -846.5 Thousand | -209.31 Thousand | - | -428.42 Thousand | -528.02 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
NWI
ALIZY
0LWH
0035
5857
GLABF